These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12809175)

  • 1. Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement.
    Murdolo G; Lucidi P; Di Loreto C; Parlanti N; De Cicco A; Fanelli C; Perriello G; Mughetti D; Pippi R; Brozzetti A; Santeusanio F; De Feo P
    J Endocrinol Invest; 2003 Mar; 26(3):244-9. PubMed ID: 12809175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term treatment with low doses of recombinant human GH stimulates lipolysis in visceral obese men.
    Lucidi P; Parlanti N; Piccioni F; Santeusanio F; De Feo P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3105-9. PubMed ID: 12107208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
    Lucidi P; Lauteri M; Laureti S; Celleno R; Santoni S; Volpi E; Angeletti G; Santeusanio F; De Feo P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):353-7. PubMed ID: 9467540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.
    Johannsson G; Mårin P; Lönn L; Ottosson M; Stenlöf K; Björntorp P; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1997 Mar; 82(3):727-34. PubMed ID: 9062473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
    Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin and the hyposomatotropism of obesity.
    Lindeman JH; Pijl H; Van Dielen FM; Lentjes EG; Van Leuven C; Kooistra T
    Obes Res; 2002 Nov; 10(11):1161-6. PubMed ID: 12429880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients.
    Edén Engström B; Burman P; Holdstock C; Karlsson FA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5193-8. PubMed ID: 14602749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone inhibition of growth hormone release stimulated by a growth hormone secretagogue: studies in the rat and dog.
    Rigamonti AE; Cella SG; Giordani C; Bonomo SM; Giunta M; Sartorio A; Muller E
    Neuroendocrinology; 2006; 84(2):115-22. PubMed ID: 17106185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ghrelin administration on decreased growth hormone status in obese animals.
    Iwakura H; Akamizu T; Ariyasu H; Irako T; Hosoda K; Nakao K; Kangawa K
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E819-25. PubMed ID: 17595213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release.
    Popovic V; Miljic D; Pekic S; Pesko P; Djurovic M; Doknic M; Damjanovic S; Micic D; Cvijovic G; Glodic J; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2187-91. PubMed ID: 15644398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients.
    Dall R; Kanaley J; Hansen TK; Møller N; Christiansen JS; Hosoda H; Kangawa K; Jørgensen JO
    Eur J Endocrinol; 2002 Jul; 147(1):65-70. PubMed ID: 12088921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake.
    Laferrère B; Hart AB; Bowers CY
    Obesity (Silver Spring); 2006 Jun; 14(6):1056-63. PubMed ID: 16861611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis.
    Vestergaard ET; Hansen TK; Nielsen S; Moller N; Christiansen JS; Jorgensen JO
    Eur J Endocrinol; 2005 Oct; 153(4):545-9. PubMed ID: 16189176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.
    Franco C; Brandberg J; Lönn L; Andersson B; Bengtsson BA; Johannsson G
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1466-74. PubMed ID: 15598680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.
    Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E891-9. PubMed ID: 17122091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.